Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data. Issue 6 (June 2020)

• Record Type: Journal Article
• Authors: Maeda, Masayuki; Muraki, Yuichi; Anno, Yuka; Sawa, Akihiro; Kusama, Yoshiki; Ishikane, Masahiro; Ohmagari, Norio; Ohge, Hiroki
• Is Part Of: Journal of infection and chemotherapy. Volume 26:Issue 6(2020:Jun.)
• Page Start: 633
• Page End: 635
• Publication Date: 2020-06
• Subjects: Antimicrobial stewardship -- Carbapenem -- Antimicrobial consumption -- Defined daily dose; ASP antimicrobial stewardship program -- DD disease and disorder -- DDD defined daily dose -- DOT days of therapy -- MDC major diagnostic category -- MHLW Ministry of Health, Labour and Welfare -- SAAR Standardized Antimicrobial Administration Ratio -- VIF variance inflation factor; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2020.02.006
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: This study aimed to develop a metric for standardized and predicted carbapenem consumption using the Diagnosis Procedure Combination payment system database and patients' characteristics. Based on Diagnosis Procedure Combination data analysis, the developed metric will provide useful benchmarks that stewardship programs can use to help drive improvements.